Key result
Elevated plasma NT-proBNP levels at admission were independently associated with an unfavorable 90-day functional outcome in patients with acute ischemic stroke.
Why the study?
Does admission NT-proBNP level predict 90-day functional outcome in patients with acute ischemic stroke?
Observational (n=217)
No
Does admission NT-proBNP level predict 90-day functional outcome in patients with acute ischemic stroke?
Elevated plasma NT-proBNP levels at admission independently predict unfavorable 90-day functional outcomes in patients with acute ischemic stroke.
Answers are grounded in this paper and cite their sources.
May inform prognosis after acute ischemic stroke; hypothesis-generating and requires prospective validation before clinical use.
The prognostic value of the N-amino terminal fragment of the prohormone brain natriuretic peptide (NT-proBNP) in acute ischemic stroke (AIS) is uncertain. We sought to determine whether NT-proBNP levels were associated with functional outcomes after AIS. From August 2012 to October 2013, consecutive first-ever AIS patients admitted to the Department of Emergency of the First Affiliated Hospital of Xinxiang Medical University, China, were included in this study. Plasma NT-proBNP levels were measured from admission. Outcomes were measured as 90-day modified Rankin Scale score ('good outcome'=0-2 vs. 'poor'). Multivariate logistic regression was used to assess associations between NT-proBNP levels and outcomes. Predictive performance of NT-proBNP as compared with the clinical model was assessed by comparing receiver-operating characteristic curves. During this study period, 217 consecutive patients with AIS were included and completed 90 days of follow-up. There was a strong positive correlation between the plasma level of NT-proBNP and the National Institutes of Health Stroke Scale score (r=0.415, P=0.000). Plasma levels of NT-proBNP in patients with an unfavorable outcome were significantly higher than those in patients with a favorable outcome [3432 (interquartile range, 1100-54991) vs. 978 (interquartile range, 123-1705) pg/ml; P=0.000]. In multivariate analyses, after adjusting for all other significant outcome predictors, the NT-proBNP level that remained can be seen as an independent unfavorable outcome predictor, with an adjusted odds ratios of 4.14 (95% confidence interval, 2.72-7.99; P=0.000). Our results show that plasma NT-proBNP levels were significantly elevated in patients with an unfavorable outcome and might be of clinical importance as a supplementary tool for the assessment of functional outcomes in patients with AIS.
No takes yet. Share an insight, caveat, or question.
Li et al. (2014) conducted an observational in Acute ischemic stroke (n=217). Elevated plasma NT-proBNP levels vs. Lower plasma NT-proBNP levels was evaluated on 90-day modified Rankin Scale score ('good outcome'=0-2 vs. 'poor') (OR 4.14, 95% CI 2.72-7.99, p=0.000). Elevated plasma NT-proBNP levels at admission were independently associated with an unfavorable 90-day functional outcome in patients with acute ischemic stroke.
Synapse has enriched 10 related papers. Consider them for comparative context: